Value through InnovationOctober 27 2016

Have any Questions or Comments?

Please contact Boehringer Ingelheim with any questions or comments.


  • U.S. Headquarters Contact Information

    Boehringer Ingelheim Pharmaceuticals, Inc.

    900 Ridgebury Rd.
    P.O. Box 368
    Ridgefield, CT 06877

For Adverse Events (Side Effects):

This website is not intended as a method of reporting adverse events or product complaints for any Boehringer Ingelheim product. Please report these adverse events or product complaints to the Medical and Technical Information Unit by calling 1-800-542-6257 (option 4).

For additional information about Boehringer Ingelheim’s clinical trials and Expanded Access Programs (EAPs), including Expanded Access Treatment Protocols and Compassionate or Emergency use of BI investigational medicines, please contact us at 1-800-542-6257.